General Information of Drug (ID:
DR0989) |
Drug Name |
Loxapine succinate
|
Synonyms |
Loxapine (succinate); Loxapine succinate; Loxapine succinate salt; Loxapine, Succinate; Loxapine,succinate; X59SG0MRYU; 2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine succinate (1:1); 2-chloro-11-(4-methyl-1-piperazinyl)dibenzo[b,f][1,4]oxazepine succinate; 27833-64-3; CAS-27833-64-3; CCRIS 1917; CL 71563; CPD000058470; DSSTox_CID_25227; DSSTox_GSID_45227; DSSTox_RID_80764; EINECS 248-682-0; MFCD00069298; MLS000069383; NCGC00016160-02; SMR000058470; UNII-X59SG0MRYU; Cloxazepin; Daxolin; Lederle
|
Indication |
Schizophrenia
[ICD11: 6A20]
|
Approved
|
[1]
|
Structure |
|
|
3D MOL is unavailable
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
445.9 |
Topological Polar Surface Area |
103 |
Heavy Atom Count |
31 |
Rotatable Bond Count |
4 |
Hydrogen Bond Donor Count |
2 |
Hydrogen Bond Acceptor Count |
7 |
Cross-matching ID |
- PubChem CID
- 71399
- ChEBI ID
-
- CAS Number
-
- TTD Drug ID
- D0U5OE
- Formula
- C22H24ClN3O5
- Canonical SMILES
- CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl.C(CC(=O)O)C(=O)O
- InChI
- 1S/C18H18ClN3O.C4H6O4/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18;5-3(6)1-2-4(7)8/h2-7,12H,8-11H2,1H3;1-2H2,(H,5,6)(H,7,8)
- InChIKey
- YQZBAXDVDZTKEQ-UHFFFAOYSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.